UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia

Leukemia, 2015-12, Vol.29 (12), p.2382-2389

2015

Volltextzugriff (PDF)

CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma

Leukemia, 2014-04, Vol.28 (4), p.917-927

2014

Volltextzugriff (PDF)

Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring

Science (American Association for the Advancement of Science), 1999-10, Vol.286 (5439), p.531-537

1999

Volltextzugriff (PDF)

Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia

Leukemia, 2015-10, Vol.29 (10), p.1981-1992

2015

Volltextzugriff (PDF)

E3 ubiquitin ligase Cbl-b activates the p53 pathway by targeting Siva1, a negative regulator of ARF, in FLT3 inhibitor-resistant acute myeloid leukemia

Leukemia, 2017-02, Vol.31 (2), p.502-505

2017

Volltextzugriff (PDF)

Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A cancer and leukemia group B study

Cancer research (Chicago, Ill.), 2001-10, Vol.61 (19), p.7233-7239

2001

Volltextzugriff (PDF)

A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia

Leukemia, 2013-10, Vol.27 (10), p.2023-2031

2013

Volltextzugriff (PDF)

Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells

Blood, 1996-04, Vol.87 (7), p.2632-2640

1996

Volltextzugriff (PDF)

Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720

Leukemia, 2011-05, Vol.25 (5), p.800-807

2011

Volltextzugriff (PDF)

The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia

Leukemia, 2012-07, Vol.26 (7), p.1713-1717

2012

Volltextzugriff (PDF)

The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation

Leukemia, 2016-04, Vol.30 (4), p.789-799

2016

Volltextzugriff (PDF)

Activating mutations in NOTCH1 in acute myeloid leukemia and lineage switch leukemias

Leukemia, 2006-11, Vol.20 (11), p.1963-1966

2006

Volltextzugriff (PDF)

Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia

Leukemia, 2015-11, Vol.29 (11), p.2143-2153

2015

Volltextzugriff (PDF)

Targeting FLT3 by chimeric antigen receptor T cells for the treatment of acute myeloid leukemia

Leukemia, 2017-08, Vol.31 (8), p.1830-1834

2017

Volltextzugriff (PDF)

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

Nature (London), 1994-02, Vol.367 (6464), p.645-648

1994

Volltextzugriff (PDF)

A phase I II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma

Leukemia, 2009-05, Vol.23 (5), p.912-918

2009

Volltextzugriff (PDF)

Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemia

Leukemia, 2016-02, Vol.30 (2), p.501-504

2016

Volltextzugriff (PDF)

Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay

Leukemia, 1998-09, Vol.12 (9), p.1482-1489

1998

Volltextzugriff (PDF)

MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition

Haematologica (Roma), 2015-05, Vol.100 (5), p.e190-e193

2015

Volltextzugriff (PDF)

The biology of human natural killer-cell subsets

Trends in Immunology, 2001-11, Vol.22 (11), p.633-640

2001

Volltextzugriff (PDF)

GAS6 expression identifies high-risk adult AML patients: potential implications for therapy

Leukemia, 2014-06, Vol.28 (6), p.1252-1258

2014

Volltextzugriff (PDF)

Interleukin 15: biology and relevance to human disease

Blood, 2001-01, Vol.97 (1), p.14-32

2001

Volltextzugriff (PDF)

Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro

The Journal of clinical investigation, 1995-12, Vol.96 (6), p.2578-2582

1995

Volltextzugriff (PDF)

Identification and Characterization of an Activating TrkA Deletion Mutation in Acute Myeloid Leukemia

Molecular and Cellular Biology, 2000-12, Vol.20 (23), p.8655-8666

2000

Volltextzugriff (PDF)

The Functional Characterization of Interleukin-10 Receptor Expression on Human Natural Killer Cells

Blood, 1995-06, Vol.85 (12), p.3577-3585

1995

Volltextzugriff (PDF)

1 – 25 von 955

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(828)
Mit Volltextzugriff
(853)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(521)
Life Sciences & Biomedicine
(478)
Humans
(452)
Biological And Medical Sciences
(260)
Medical Sciences
(217)
Male
(187)
Female
(183)
Animals
(174)
Middle Aged
(148)
Hematology
(127)
Mice
(127)
Adult
(116)
Aged
(105)
Oncology
(100)
Killer Cells, Natural - Immunology
(89)
Immunology
(71)
Hematologic And Hematopoietic Diseases
(67)
Pharmacology. Drug Treatments
(61)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(60)
Cells, Cultured
(55)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia

CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma

Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring

Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia

E3 ubiquitin ligase Cbl-b activates the p53 pathway by targeting Siva1, a negative regulator of ARF, in FLT3 inhibitor-resistant acute myeloid leukemia

Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A cancer and leukemia group B study

A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia

Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells

Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720

The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia

The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation

Activating mutations in NOTCH1 in acute myeloid leukemia and lineage switch leukemias

Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia

Targeting FLT3 by chimeric antigen receptor T cells for the treatment of acute myeloid leukemia

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

A phase I II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma

Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemia

Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay

MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition

The biology of human natural killer-cell subsets

GAS6 expression identifies high-risk adult AML patients: potential implications for therapy

Interleukin 15: biology and relevance to human disease

Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro

Identification and Characterization of an Activating TrkA Deletion Mutation in Acute Myeloid Leukemia

The Functional Characterization of Interleukin-10 Receptor Expression on Human Natural Killer Cells

Suchergebnisse filtern